Swiss Parliament Approves Mandatory Electronic Prescriptions.

Switzerland is taking a major step toward digitalising its healthcare system after the Swiss parliament approved new rules making electronic prescriptions and medication plans compulsory.

The Senate passed the amendments to the Therapeutic Products Act on Thursday in an overwhelming vote of 33 to 1, signaling strong political support for the reform. The primary goal of the change is to improve patient safety and reduce medication errors.

Under the new regulation, healthcare professionals will be required to issue prescriptions exclusively in electronic form. This applies not only to prescriptions but also to medication plans used by patients and medical providers.

Authorities believe that the digital system will reduce the risk of incorrect drug dispensing and improve coordination between doctors, pharmacies, and other healthcare professionals. By enabling better information exchange, the system aims to make treatment more efficient and transparent.

Despite the shift to digital prescriptions, patients will still retain flexibility. Individuals will be able to request a printed copy of their electronic medication plan if needed, ensuring accessibility for those less comfortable with digital tools.

The reform is part of Switzerland’s broader effort to modernize its healthcare infrastructure and integrate digital solutions into everyday medical practice. Officials say this transformation is essential for improving efficiency, safety, and long-term system sustainability.

Health authorities also expect that digital prescriptions will help address challenges such as medicine shortages by improving tracking and coordination across the supply chain.

The new system marks a significant milestone in Switzerland’s healthcare digitalisation strategy and is expected to be implemented across the country in the coming years.

Swiss Doctors Still Face Burnout Concerns.

Doctors working in Swiss hospitals are experiencing a slight reduction in weekly working hours, according to a new survey. While this marks a positive development for the healthcare sector, concerns about exhaustion and patient safety remain widespread.

The survey, conducted among 2,400 doctors by the Demoscope research institute on behalf of the Association of Swiss Assistant and Senior Physicians (VSAO), found that the average weekly workload has fallen to 54.6 hours. In 2022, doctors reported working an average of 56.3 hours per week.

The findings also show an improvement in compliance with labour regulations. The percentage of doctors reporting violations of working time laws decreased from 68% to 58%, indicating gradual progress in hospital working conditions.

Despite these improvements, fatigue continues to affect a large portion of the medical workforce. More than half of the doctors surveyed said they regularly reach a point where they feel unable to continue due to physical or mental exhaustion. The level of stress remains almost unchanged compared with previous years.

Patient safety is another major concern highlighted in the report. Nearly 60% of respondents stated that they had witnessed situations in the past two years where patients were placed at risk because of fatigue caused by excessive workloads. Medical professionals warn that long working hours and ongoing pressure can affect concentration, decision-making, and overall quality of care.

Healthcare experts believe that further reforms are needed to improve staffing levels, reduce pressure on medical teams, and protect both doctors and patients. While the reduction in working hours is a positive sign, the latest findings suggest that burnout and workplace stress continue to be serious challenges within Switzerland’s healthcare system.

The survey serves as an important reminder that maintaining a healthy and sustainable workforce is essential for delivering safe and effective healthcare across Switzerland. As hospitals face increasing demand for services, ensuring the wellbeing of medical professionals will remain a key priority.

AI-Designed Vaccine Successfully Tested in Human Trial.

Scientists at the University of Cambridge have successfully completed early human trials of a new artificial intelligence-designed vaccine called pEVAC-PS, marking a major breakthrough in medical technology and infectious disease prevention.

The vaccine was developed using advanced AI systems that analyzed global genomic data to identify shared characteristics across multiple viruses. This approach allowed researchers to design a broad-spectrum antigen capable of targeting a wide range of coronavirus-related strains.

Unlike traditional vaccines, pEVAC-PS was administered using a microfluid jet-like delivery device that injects the vaccine into the skin without a conventional needle. Researchers say this method could improve precision and patient comfort in future immunizations.

The clinical trial involved 39 healthy volunteers aged between 18 and 50. Participants were recruited from medical research centers in Southampton and Cambridge, where they received different dosage levels ranging from 0.2 mg to 1.2 mg.

The results showed that the vaccine was well tolerated, with no significant adverse side effects reported during the initial trial phase. Scientists confirmed that the study demonstrated both safety and early immune response potential.

The AI system behind the vaccine was trained to identify a common antigen structure shared among Sarbeco coronavirus family members, including SARS-CoV-2, SARS, and other related bat-origin coronaviruses. This could allow the vaccine to provide broader protection against future emerging variants.

Researchers believe this approach could revolutionize vaccine development by enabling faster design of treatments for viruses such as influenza, Ebola, and other high-risk pathogens.

Experts involved in the study say AI-driven vaccine design may significantly shorten development time and improve global preparedness for future pandemics.

India Introduces AI App for Newborn Health Monitoring.

The state government of Andhra Pradesh in India has launched a new artificial intelligence-based mobile application designed to assess the health of newborn babies more efficiently and accurately.

The app, named “Shishu Maapan,” uses advanced AI technology to measure key health indicators of infants without requiring direct physical contact. Health workers can record a simple mobile video, which the system then analyzes to estimate important measurements.

Through this video-based assessment system, the app can calculate a newborn’s weight, height, head circumference, and chest circumference with high precision. Officials say this reduces manual measurement errors and improves data accuracy in healthcare reporting.

The initiative is aimed at strengthening child healthcare services, especially in rural and remote regions where access to medical equipment and specialists may be limited. The AI-powered system allows healthcare workers to quickly evaluate newborn health conditions in the field.

Authorities believe the application will play a significant role in monitoring early childhood development and maintaining accurate digital health records. It is also expected to support long-term healthcare planning and early intervention strategies.

Officials further stated that “Shishu Maapan” is part of a broader effort to integrate artificial intelligence into public healthcare systems. The goal is to improve efficiency, reduce workload for medical staff, and ensure faster health assessments for newborns.

By combining mobile technology with AI-driven analytics, the system represents a significant step forward in digital healthcare innovation in India.

Swiss Government Targets Better Endometriosis Treatment.

The Swiss government has announced new measures to improve the diagnosis and treatment of endometriosis, a condition that affects approximately one in ten women of childbearing age. Officials say there is a clear need for action to ensure earlier diagnosis, better treatment quality, and stronger support for women living with the disease.

According to a newly approved government report, many women with endometriosis experience symptoms for years before receiving an accurate diagnosis. The condition can cause severe menstrual pain, chronic pelvic pain, fatigue, anxiety, and fertility difficulties, significantly affecting daily life, education, employment, and personal relationships.

The government acknowledges that challenges surrounding endometriosis reflect broader structural weaknesses in the healthcare system when it comes to managing conditions that primarily affect women. As a result, improving care for endometriosis patients has become part of a wider effort to strengthen women’s health services across Switzerland.

Several initiatives are already underway. The Federal Commission for Quality has been instructed to include female-specific diseases in its strategic objectives. In addition, a national study examining the quality of treatment for these conditions is currently in progress, with endometriosis included among the key focus areas.

The Federal Office of Public Health (FOPH) has also been tasked with exploring ways to analyze existing healthcare data related to women affected by endometriosis. This work will be carried out in collaboration with the Swiss Health Observatory to better understand patient experiences and treatment outcomes.

While the government is supporting research and policy improvements, it emphasizes that healthcare professionals, hospitals, medical societies, educational institutions, and patient organizations also play a critical role in ensuring timely diagnosis and effective treatment.

Officials are calling for greater awareness of endometriosis in healthcare settings, workplaces, and educational institutions. They believe that increased public understanding, improved research, and coordinated care strategies can help reduce diagnosis delays and improve the quality of life for thousands of women across Switzerland.

The initiative represents an important step toward addressing long-standing gaps in women’s healthcare and ensuring that endometriosis receives the attention it deserves within the Swiss healthcare system.

Swiss and Belgian Doctors Launch Charity for Burn Victims After Crans-Montana Tragedy.

Five months after the devastating Crans-Montana bar fire that claimed 41 lives and injured more than 100 people, Swiss and Belgian medical professionals have launched a new charity initiative aimed at supporting burn victims and advancing burn treatment research.

The organization, known as Initiative Phoenix, brings together a team of experienced surgeons and specialists from Switzerland and Belgium. The charity seeks to improve care for people suffering from severe burn injuries while promoting medical innovation and international collaboration among healthcare professionals.

Belgian plastic surgeon Dr. Johann Wary, who lives near the site of the tragedy and works at a nearby clinic, has been appointed president of the association. He explained that the project was inspired by the profound impact the disaster had on local communities and healthcare professionals involved in treating victims.

The association’s vice-president is former Michelin-starred chef Didier de Courten, who said the tragedy deeply affected those connected to the hospitality sector. He emphasized the importance of supporting initiatives that help victims and their families rebuild their lives.

Initiative Phoenix is supported by a scientific committee comprising leading Swiss and Belgian surgeons, including specialists from Lausanne University Hospital (CHUV). The committee aims to encourage research, share expertise, and develop new treatment approaches for patients with severe burn injuries.

All medical experts involved in the project are volunteering their services. The association plans to provide guidance and support to victims and their families without financial interest. It also hopes to raise funds for research projects, scholarships for young plastic surgeons, and medical treatments not fully covered by insurance.

In addition, Initiative Phoenix plans to organize an annual international scientific symposium in Crans-Montana focused on burn injury treatment and recovery. The first conference could take place in early 2027.

The launch of Initiative Phoenix represents a significant step toward improving long-term support for burn victims while strengthening international cooperation in medical research and patient care.

Association for Burn Victims Founded After Crans-Montana Fire.

A new organisation called Initiative Phoenix has been founded in Switzerland to support victims of the devastating Crans-Montana fire disaster, which killed 41 people and left 115 injured.

The association was created five months after the tragedy and aims to improve medical care, rehabilitation, and long-term support for burn victims. It focuses on promoting medical innovation in burn treatment and strengthening cooperation between international specialists.

Initiative Phoenix also plans to develop practical therapeutic guidelines for victims and their families. These recommendations will be created through collaboration between doctors and experts, allowing affected individuals to access structured medical and psychological support.

The organisation will further support humanitarian, scientific, and social initiatives related to severe accident recovery. A key goal is to improve coordination between medical institutions treating serious burn injuries across Switzerland and abroad.

The project was initiated by Belgian plastic surgeon Johann Wary, who resides in Crans-Montana. He is supported by a medical committee consisting of six Swiss and Belgian doctors, including specialists from CHUV Lausanne, one of Switzerland’s leading university hospitals.

The initiative reflects growing efforts to provide long-term care and structured recovery pathways for victims of large-scale disasters.

EU Antibiotic Security at Risk, Warns Sandoz.

Swiss-based pharmaceutical company Sandoz has raised serious concerns over the growing import of low-cost antibiotics from China, warning that it could threaten Europe’s healthcare security and industrial stability.

Complaint Filed to European Commission

Sandoz has submitted a draft complaint to the European Commission targeting imports of penicillin-based antibiotics, particularly the active ingredient used in amoxicillin. The company argues that heavily subsidized Chinese production is distorting global competition.

Concerns Over Market Dependency

According to Sandoz CEO Richard Saynor, up to 90% of global antibiotic active substances are now produced outside Europe, mainly in China. He warned that this creates a critical strategic vulnerability for public health systems and crisis preparedness across Europe.

Pricing and Industry Pressure

Sandoz claims that antibiotics are being systematically undervalued in global markets, with pricing structures failing to reflect their importance in healthcare systems. The company argues that this focus on low-cost supply is weakening long-term production sustainability.

Risk to European Production Capacity

The company is actively trying to maintain Europe’s last remaining major antibiotic production facility in Kundl, Austria, which marks its 80th anniversary this year. Industry leaders warn that without stronger protections, Europe risks losing domestic production capability entirely.

Policy Response in Europe

Some progress has been made through initiatives such as the “Alpbach Communiqué,” which proposes that at least 30% of essential medicine supplies should come from European producers.

The EU’s proposed Critical Medicines Act is also seen as a step forward, although implementation details remain uncertain.

Global Comparison and Policy Debate

Sandoz has pointed to India’s policy model, where minimum import pricing is used to protect domestic pharmaceutical production. The company argues that Europe may need similar measures to secure long-term supply stability.

Conclusion

The dispute highlights growing global tensions over pharmaceutical supply chains, pricing fairness, and strategic independence in essential medicines, particularly antibiotics.

Swiss Scientists Develop New Gene Clock.

An international research team with Swiss participation has developed advanced “gene clocks” capable of measuring biological age and predicting lifespan in real time. The breakthrough study could transform future ageing research and health monitoring.

Scientists analysed more than 11,000 tissue samples collected from mice, rats, macaques, and humans. Researchers discovered that molecular ageing patterns inside the transcriptome remain remarkably similar across species and cell types.

The study reveals that ageing activates genes linked to inflammation, cell damage, and programmed cell death. At the same time, genes responsible for tissue repair, wound healing, and regeneration become less active as the body grows older.

Using this data, researchers created highly dynamic transcriptome clocks that can measure biological ageing more accurately. To validate the technology for humans, scientists tested the system using data from over 50,000 participants in the UK Biobank.

Experts say the new gene clocks perform similarly to modern epigenetic ageing clocks already used in scientific research. However, transcriptome clocks offer a major advantage because they respond quickly to changes happening inside cells in real time.

Researchers believe this technology could help scientists evaluate the effectiveness of anti-ageing treatments, diets, and medicines much faster than current methods. The discovery may open new opportunities in personalised healthcare and longevity research.

The study involved ETH Zurich researcher Adrian Molière and was led by Harvard Medical School scientist Vadim Gladyshev.

Swiss Health Insurance Premiums to Rise 5% in Autumn.

Health insurance premiums in Switzerland are set to increase by around 5% in autumn 2026, according to new projections from the Federal Office of Public Health. The announcement was made during a media briefing in Bern on Tuesday, where officials highlighted the continued rise in healthcare costs across the country.

Swiss healthcare spending has increased significantly, with costs rising by an additional CHF247 per capita last year. Authorities confirm that this upward trend is expected to continue, driven by multiple long-term factors affecting the healthcare system.

Officials from the Federal Office of Public Health stated that premium increases are closely linked to overall cost growth in the healthcare sector. On average, insurers expect costs to rise by nearly 5% in 2026, which directly influences the adjustment of monthly premiums paid by residents.

Experts explain that the rise in healthcare expenses is due to several structural factors, including an ageing population, advances in medical technology, and increasing demand for healthcare services. These elements continue to place pressure on Switzerland’s insurance-based healthcare model.

Cost growth in the first quarter of the current year was recorded at approximately 2.9%, confirming that medical spending remains on an upward trajectory. Authorities have stressed that controlling costs remains a long-term challenge for policymakers and insurers alike.

The Federal Office of Public Health emphasized that while the Swiss healthcare system remains high-quality and efficient, sustained efforts are needed to manage expenditure growth and ensure long-term affordability for citizens.

As premiums continue to rise, public debate in Switzerland is expected to intensify around healthcare reform, insurance affordability, and cost control measures in the coming years.